Free Trial

Lonza Group (OTCMKTS:LZAGY) Shares Up 0.2% - Here's Why

Lonza Group logo with Medical background

Key Points

  • Lonza Group AG shares rose by 0.2% during mid-day trading, with a trading increase to $71.52 before settling at $70.79.
  • The company's debt-to-equity ratio stands at 0.45, and it shows solid liquidity with a current ratio of 1.52.
  • Lonza operates across multiple segments including Biologics, Small Molecules, and Cell & Gene, serving various international markets.
  • Looking to export and analyze Lonza Group data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Lonza Group Ag (OTCMKTS:LZAGY - Get Free Report) traded up 0.2% during mid-day trading on Monday . The company traded as high as $71.52 and last traded at $70.79. 19,600 shares were traded during mid-day trading, a decline of 35% from the average session volume of 30,303 shares. The stock had previously closed at $70.64.

Lonza Group Stock Performance

The company has a debt-to-equity ratio of 0.45, a current ratio of 1.52 and a quick ratio of 1.04. The stock's 50-day moving average price is $69.87 and its 200-day moving average price is $67.47.

Lonza Group Company Profile

(Get Free Report)

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Lonza Group Right Now?

Before you consider Lonza Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lonza Group wasn't on the list.

While Lonza Group currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: All Signs Point to More Growth Ahead
3 Quiet Growth Stocks With Major Momentum
The Market’s Next Big Winners? Start Here

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines